Updated on 03/16/2021
Billing Codes and Rates issued for the J&J Covid-19 Vaccine
The Centers for Medicare & Medicaid Services (CMS) has updated the COVID-19 vaccine billing and coding list to reflect the newly Federal Drug Administration (FDA) approved, Johnson & Johnson (J&J) vaccine. The J&J vaccine was approved through emergency use authorization and is listed as the Janssen Biotech, Inc. vaccine, the pharmaceutical companies of J&J.
The update includes a fact sheet to guide providers in administering the J&J vaccine.
The billing and coding list also includes billing codes and rates for an AstraZeneca vaccine, with an effective date TBD. An AstraZeneca vaccine has yet to receive FDA approval. It is unknown whether this suggests that the approval of a forth COVID-19 vaccine is anticipated.
Click here for more information on COVID-19 vaccines and monoclonal antibodies therapy.
Article published by NAHC on March 08, 2021
CLICK HERE to read original post